EBITDA Margin ratio Analysis of Glaxosmithkline Pharmaceuticals Ltd. - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPoint
Beta&Vols
Tech ChartsLatest FY EBITDA Margin
Period Ending - Mar-25
Very Good EBITDA Margin
35.42
Period Ending - Mar-24
Very Good EBITDA Margin
25.70
Growth
37.81 %
Trailing Twelve Months EBITDA Margin
Period Ending - Mar-25
Very Good EBITDA Margin
36.28
Most recent Quarter EBITDA Margin
Period Ending - Jun-25
Very Good EBITDA Margin
36.63
EBITDA Margin Analysis of Glaxosmithkline Pharmaceuticals Ltd.
| Ebitda Margin Ratio of Glaxosmithkline Pharmaceuticals Ltd. with value of 36.28 means that its operating expenses are lower in relation to total revenue in trailing twelve months. |
| Ebitda Margin Ratio of Glaxosmithkline Pharmaceuticals Ltd. with value of 36.63 means that its operating expenses are lower in relation to total revenue latest Quarter ending on Jun-25. |
| EBITDA Margin Ratio of GLAXO rose handsomely by 37.81 % this year. |
| EBITDA Margin Ratio with value of 35.42 was highest in Year Mar-25 in last Five Years. |
| EBITDA Margin Ratio with value of 18.33 was lowest in Year Mar-21 in last Five Years. |
| Latest EBITDA Margin Ratio with value of 35.42 is Greater than Average EBITDA Margin of 26.63 in last five years. |
Other EBITDA Margin Related Info of GLAXO that may interest you.
Glaxosmithkline Pharmaceuticals Ltd. Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| GLAXO | 2618.60 | 2621.70 | 0.118 % | Drugs & Pharma |
Defination of EBITDA Margin
EBITDA Margin is the profitability ratio that measures a company's earnings before interest, taxes, depreciation, and amortization as a percentage of revenue. EBITDA is the abbreviation for Earnings before Interest, Taxes, Depreciation, and Amortization. more ..
EBITDA Margin Related Ratios
| NetProfitMargin | ReturnOnEquity |
Tsr Profitability Index
| Mild Profitability | Screener |
FY - Historical EBITDA Margin of Glaxosmithkline Pharmaceuticals Ltd.
| Period | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 |
|---|---|---|---|---|---|---|---|
| EBITDA Margin | 35.42 | 25.70 | 27.80 | 25.91 | 18.33 | 12.24 | 23.39 |
| Change | 37.81 % | -7.55 % | 7.31 % | 41.37 % | 49.67 % | -47.67 % | 16.19 % |
| Price | 2880.35 | 1946.60 | 1324.75 | 1666.90 | 1440.75 | 1257.40 | 1297.45 |
| Price Change | 47.97 % | 46.94 % | -20.53 % | 15.70 % | 14.58 % | -3.09 % | 24.29 % |